Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Silvia Díaz-Cerezo"'
Autor:
Patricia Pozo-Rosich, David García-Azorín, Silvia Díaz-Cerezo, Julia Fernández-Montoya, Héctor David de Paz, Mercedes Núñez
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionIn the context of migraine preventive therapy, new therapeutic modalities such as monoclonal antibodies targeting the calcitonin gene-related peptide receptor (CGRP) or ligand offer potential advantages over traditional preventive treatme
Externí odkaz:
https://doaj.org/article/1702f60c5e90429ab967bad3fefada56
Autor:
Beatriz Joven, Raquel Hernández Sánchez, Eva Pérez-Pampín, Ángel Aragón Díez, Raquel Almodóvar, Ángels Martínez-Ferrer, Joaquín Belzunegui, Esteban Rubio, Silvia Díaz-Cerezo, Sebastián Moyano, Manuel Gómez-Barrera, María Yébenes, Mercedes Núñez
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1319-1333 (2023)
Abstract Introduction Ixekizumab (IXE) is an IgG4-type monoclonal antibody targeting IL-17A indicated alone or in combination with methotrexate, for the treatment of active psoriatic arthritis (PsA) in adult patients with insufficient response or wit
Externí odkaz:
https://doaj.org/article/430df2da23da419d92b2e5be91122189
Autor:
Julio Pascual, Mercedes Núñez, Tommaso Panni, Silvia Díaz-Cerezo, Diego Novick, Antonio Ciudad
Publikováno v:
Pain and Therapy, Vol 12, Iss 5, Pp 1209-1220 (2023)
Abstract Introduction This analysis aimed to evaluate demographics, migraine-related disability, symptoms, diagnosis and healthcare consultation, work productivity, and treatment patterns according to headache frequency in adults with migraine in the
Externí odkaz:
https://doaj.org/article/6b1677520a5746af89ec38d0f2347230
Autor:
F. Javier Ampudia‐Blasco, Natalia Duque, Esther Artime, Elena Caveda, Erik Spaepen, Silvia Díaz‐Cerezo, Miriam Rubio‐ deSantos, Daniel Callejo Velasco, M. Pilar Bahíllo‐Curieses
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 6, Iss 6, Pp n/a-n/a (2023)
Abstract Introduction Insulin lispro 100 units/mL Jr KwikPen is the first prefilled, disposable, half‐unit insulin pen that delivers 0.5–30 units in increments of 0.5 units for the treatment of patients with diabetes. This study describes the pro
Externí odkaz:
https://doaj.org/article/587b8576001746fc970ed5717d556853
Autor:
José Antonio Sacristán, Tatiana Dilla, Silvia Díaz-Cerezo, Clara Gabás-Rivera, Susana Aceituno, Luis Lizán
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234705 (2020)
IntroductionRecommendations on chronic diseases management emphasise the need to consider patient perspectives and shared decision-making. Discrepancies between patients and physicians' perspectives on treatment objectives, disease activity, preferen
Externí odkaz:
https://doaj.org/article/c408b5d59dfa44c5801fb10ed545a43a
Autor:
Manuel Barreiro-de Acosta, Alberto Molero, Esther Artime, Silvia Díaz-Cerezo, Luis Lizán, Héctor David de Paz, María Dolores Martín-Arranz
Publikováno v:
Advances in Therapy. 40:1975-2014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f9f8cd71e818ed1401f01a9b65895a
https://doi.org/10.1007/s12325-023-02473-6
https://doi.org/10.1007/s12325-023-02473-6
Autor:
Ángel Luis Guerrero-Peral, Jesús Porta-Etessam, Jaime Rodríguez-Vico, Mercedes Núñez, Antonio Ciudad, Silvia Díaz-Cerezo, Carla Garí-Peris, Francisco Javier Pérez-Sádaba, Luis Lizán, Sonia Santos-Lasaosa
Publikováno v:
Patient Preference and Adherence. 16:3291-3302
Ãngel Luis Guerrero-Peral,1 Jesús Porta-Etessam,2 Jaime RodrÃguez-Vico,3 Mercedes Núñez,4 Antonio Ciudad,4 Silvia DÃaz-Cerezo,4 Carla GarÃ-Peris,5 Francisco Javier Pérez-Sádaba,5 Luis Lizán,5 Sonia Santos-Lasaosa6 1Heada
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908f7420828d8ab594c2572c6fe80c06
https://doi.org/10.2147/ppa.s384333
https://doi.org/10.2147/ppa.s384333
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 70:155-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492f0561f934c8787a4938859d147a7d
https://doi.org/10.1016/j.endien.2022.10.006
https://doi.org/10.1016/j.endien.2022.10.006
Autor:
Salvador Blanch, Juan Miguel Gil-Gil, Miriam Arumí, Elena Aguirre, Miguel Ángel Seguí, Manuel Atienza, Silvia Díaz-Cerezo, Alberto Molero, José Manuel Cervera, Joaquín Gavilá
Publikováno v:
Clinical and Translational Oncology.
Introduction/objectives To describe abemaciclib use in patients with hormone receptor-positive, human epidermal growth factor receptor-negative (HR+/HER2−) metastatic breast cancer (mBC) who participated in the Named Patient Use program (NPU) in Sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f37bc279332f0f7607ff636650b20d49
https://doi.org/10.1007/s12094-023-03159-9
https://doi.org/10.1007/s12094-023-03159-9
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
Autor:
Beatrice Osumili, Esther Artime, Beth Mitchell, Miriam Rubio-de Santos, Silvia Díaz-Cerezo, Marga Giménez, Erik Spaepen, Helen Sharland, William J. Valentine
Publikováno v:
Diabetes Therapy. 13:775-794
Severe hypoglycemic events (SHE) represent a clinical and economic burden in patients with diabetes. Nasal glucagon (NG) is a novel treatment for SHEs with similar efficacy, but with a usability advantage over injectable glucagon (IG) that may transl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06db278a7fbd5813ac8478019c955806
https://doi.org/10.1007/s13300-022-01238-8
https://doi.org/10.1007/s13300-022-01238-8